C9orf72 Expansion Creates the Unstable Folate-Sensitive Fragile Site FRA9A

Mila Mirceta,Monika H M Schmidt,Natalie Shum,Tanya K Prasolava,Bryanna Meikle,Stella Lanni,Mohiuddin,Paul M Mckeever,Ming Zhang,Minggao Liang,Ilse van der Werf,Stefaan Scheers,Patrick A Dion,Peixiang Wang,Michael D Wilson,Theresa Abell,Elliot A Philips,Łukasz J Sznajder,Maurice S Swanson,Mustafa Mehkary,Mahreen Khan,Katsuyuki Yokoi,Christine Jung,Pieter J de Jong,Catherine H Freudenreich,Philip McGoldrick,Ryan K C Yuen,Agessandro Abrahão,Julia Keith,Lorne Zinman,Janice Robertson,Ekaterina Rogaeva,Guy A Rouleau,R Frank Kooy,Christopher E Pearson
DOI: https://doi.org/10.1101/2024.10.26.620312
2024-01-01
Abstract:The hyper-unstable Chr9p21 locus, harbouring the interferon gene cluster, oncogenes andC9orf72, is linked to multiple diseases.C9orf72(GGGGCC)n expansions (C9orf72Exp) are associated with incompletely penetrant amyotrophic lateral sclerosis, frontotemporal dementia and autoimmune disorders.C9orf72Exp patients display hyperactive cGAS-STING-linked interferon immune and DNA damage responses, but the source of immuno-stimulatory or damaged DNA is unknown. Here, we showC9orf72Exp in pre-symptomatic and ALS-FTD patient cells and brains cause the folate-sensitive chromosomal fragile site, FRA9A. FRA9A centers on >33kb ofC9orf72as highly-compacted chromatin embedded in an 8.2Mb fragility zone spanning 9p21, encompassing 46 genes, making FRA9A one of the largest fragile sites.C9orf72Exp cells show chromosomal instability, heightened global- and Chr9p-enriched sister-chromatid exchanges, truncated-Chr9s, acentric-Chr9s and Chr9-containing micronuclei, providing endogenous sources of damaged and immunostimulatory DNA. Cells from oneC9orf72Exp patient contained highly-rearranged FRA9A-expressing Chr9 with Chr9-wide dysregulated gene expression. SomaticC9orf72Exp repeat instability and chromosomal fragility are sensitive to folate-deficiency. Age-dependent repeat instability, chromosomal fragility, and chromosomal instability can be transferred to CNS and peripheral tissues of transgenicC9orf72Exp mice, implicatingC9orf72Exp as the source. Our results highlight unappreciated effects ofC9orf72expansions that trigger vitamin-sensitive chromosome fragility, adding structural variations to the disease-enriched 9p21 locus, and likely elsewhere.
What problem does this paper attempt to address?